Literature DB >> 23425605

The role of de novo catecholamine synthesis in mediating methylmercury-induced vesicular dopamine release from rat pheochromocytoma (PC12) cells.

Chelsea T Tiernan1, Ethan A Edwin, John L Goudreau, William D Atchison, Keith J Lookingland.   

Abstract

The purpose of this study was to characterize methylmercury (MeHg)-induced dopamine (DA) release from undifferentiated pheochromocytoma (PC12) cells and to examine the potential role for DA synthesis in this process. MeHg caused a significant increase in DA release that was both concentration- and time-dependent. DA release was significantly increased by 2µM MeHg at 60min and by 5µM MeHg at 30min; 1µM MeHg was without effect. Because DA release induced by 5µM MeHg was associated with a significant percentage of cell death at 60 and 120min, 2µM MeHg was chosen for further characterization of release mechanisms. MeHg-induced DA release was attenuated but not abolished in the absence of extracellular calcium, whereas the vesicular content depleting drug reserpine (50nM) abolished release. Thus, MeHg-induced DA release requires vesicular exocytosis but not extracellular calcium. MeHg also increased intracellular DA and the rate of DA storage utilization, suggesting a role for DA synthesis in MeHg-induced DA release. The tyrosine hydroxylase inhibitor α-methyltyrosine (300µM, 24h) completely abolished MeHg-induced DA release. MeHg significantly increased DA precursor accumulation in cells treated with 3-hydroxybenzylhydrazine (10µM), revealing that MeHg increases tyrosine hydroxylase activity. Overall, these data demonstrate that MeHg facilitates DA synthesis, increases intracellular DA, and augments vesicular exocytosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23425605      PMCID: PMC3627552          DOI: 10.1093/toxsci/kft025

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  40 in total

Review 1.  Presynaptic regulation of dopaminergic neurotransmission.

Authors:  Yvonne Schmitz; Marianne Benoit-Marand; François Gonon; David Sulzer
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

Review 2.  Plasma membrane monoamine transporters: structure, regulation and function.

Authors:  Gonzalo E Torres; Raul R Gainetdinov; Marc G Caron
Journal:  Nat Rev Neurosci       Date:  2003-01       Impact factor: 34.870

Review 3.  Disruption of intraneuronal divalent cation regulation by methylmercury: are specific targets involved in altered neuronal development and cytotoxicity in methylmercury poisoning?

Authors:  Tobi L Limke; Steven R Heidemann; William D Atchison
Journal:  Neurotoxicology       Date:  2004-09       Impact factor: 4.294

4.  Mechanisms of inhibition of active transport ATPases by mercurials.

Authors:  G G Berg; E F Miles
Journal:  Chem Biol Interact       Date:  1979-10       Impact factor: 5.192

5.  Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter.

Authors:  L R F Faro; J L M do Nascimento; M Alfonso; R Durán
Journal:  Neurochem Int       Date:  2002-04       Impact factor: 3.921

6.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

Authors:  A Carlsson; J N Davis; W Kehr; M Lindqvist; C V Atack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation.

Authors:  I J Kopin; G R Breese; K R Krauss; V K Weise
Journal:  J Pharmacol Exp Ther       Date:  1968-06       Impact factor: 4.030

8.  Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.

Authors:  B B Brodie; E Costa; A Dlabac; N H Neff; H H Smookler
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

9.  Methylmercury cytotoxicity in PC12 cells is mediated by primary glutathione depletion independent of excess reactive oxygen species generation.

Authors:  Rita Gatti; Silvana Belletti; Jacopo Uggeri; Maria Vittoria Vettori; Antonio Mutti; Renato Scandroglio; Guido Orlandini
Journal:  Toxicology       Date:  2004-11-15       Impact factor: 4.221

10.  Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheo-chromocytoma cells.

Authors:  L A Greene; G Rein
Journal:  Brain Res       Date:  1977-07-01       Impact factor: 3.252

View more
  5 in total

1.  Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase.

Authors:  Chelsea T Tiernan; Ethan A Edwin; Hae-Young Hawong; Mónica Ríos-Cabanillas; John L Goudreau; William D Atchison; Keith J Lookingland
Journal:  Toxicol Sci       Date:  2015-01-19       Impact factor: 4.849

2.  Effects of adolescent exposure to methylmercury and d-amphetamine on reversal learning and an extradimensional shift in male mice.

Authors:  Steven R Boomhower; M Christopher Newland
Journal:  Exp Clin Psychopharmacol       Date:  2017-03-13       Impact factor: 3.157

3.  The putative multidrug resistance protein MRP-7 inhibits methylmercury-associated animal toxicity and dopaminergic neurodegeneration in Caenorhabditis elegans.

Authors:  Natalia VanDuyn; Richard Nass
Journal:  J Neurochem       Date:  2013-11-25       Impact factor: 5.372

4.  Latent alterations in swimming behavior by developmental methylmercury exposure are modulated by the homolog of tyrosine hydroxylase in Caenorhabditis elegans.

Authors:  Tao Ke; Lisa M Prince; Aaron B Bowman; Michael Aschner
Journal:  Neurotoxicol Teratol       Date:  2021-02-21       Impact factor: 3.763

5.  Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission.

Authors:  Youichi Shinozaki; Masatoshi Nomura; Ken Iwatsuki; Yoshinori Moriyama; Christian Gachet; Schuichi Koizumi
Journal:  Sci Rep       Date:  2014-03-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.